Multicomponent reactions for protein tyrosine phosphatase inhibitors

Area of Science:

• Biochemistry
• Medicinal Chemistry
• Drug Discovery

Background:

• Protein tyrosine phosphatases (PTPs) are crucial in cellular signaling and disease, making them key therapeutic targets.
• Developing selective PTP inhibitors is difficult due to conserved active sites and poor drug-like properties of existing compounds.

Purpose of the Study:

• To provide a systematic overview of multicomponent reactions (MCRs) for discovering protein tyrosine phosphatase (PTP) inhibitors.
• To highlight how MCRs facilitate the rapid synthesis and optimization of novel PTP inhibitor scaffolds.

Main Methods:

• Review of MCR strategies applied to PTP inhibitor development.
• Analysis of MCR-driven library synthesis, scaffold identification, and optimization.
• Discussion of key design principles like phosphotyrosine mimicry and conformational constraint.

Main Results:

• MCRs enable rapid, modular synthesis of diverse, drug-like PTP inhibitor scaffolds.
• MCRs facilitate optimization of inhibitor properties such as polarity, rigidity, and target engagement.
• This approach accelerates the identification of potent and selective PTP inhibitors.

Conclusions:

• MCRs are powerful, design-enabling technologies for next-generation PTP inhibitor development.
• Integration of AI and virtual screening with MCRs offers future opportunities for PTP drug discovery.